UVV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
UVV is not a good buy right now for an impatient investor. The stock is extended near resistance with overbought momentum (RSI 75.7) and no proprietary buy signals today, while pattern-based probabilities lean to mild downside over the next day/week/month. If you want to act immediately, this setup is better suited to waiting for a pullback toward support (55.2 or below) rather than buying at 56.6 into resistance.
Trend/Momentum: MACD histogram is positive (0.15) and expanding, which supports an ongoing upswing. However, RSI_6 at ~75.75 is effectively overbought, increasing the odds of a near-term pullback or consolidation. Moving averages: Converging MAs suggest the trend is not strongly separated—momentum exists, but it’s not a clean, powerful trend state. Key levels: Pivot 55.219. Immediate resistance R1 56.449 (price ~56.59 is already above/at this zone) and next resistance R2 57.209. Supports: S1 53.989, S2 53.229. With price pressing resistance and RSI elevated, risk/reward for a fresh entry is unfavorable. Near-term pattern odds: Similar-pattern model shows ~50% chance of -4.36% next day, -2.51% next week, -1.91% next month—tilting bearish short-term.
Intellectia Proprietary Trading Signals
Upcoming earnings catalyst: QDEC 2025 earnings on 2026-02-11 after hours (Est. EPS 1.92). A strong report could re-rate the stock.
Options positioning is bullish (call-heavy put/call ratios).
Latest quarter shows solid top-line and EPS growth (see financials).
Technicals are stretched: RSI is overbought and price is pushing into resistance (56.45–57.21 zone).
Pattern-based forward return distribution skews mildly negative over the next day/week/month.
Profitability pressure: Gross margin declined YoY, which can weigh on valuation if it persists.
No supportive news flow in the last week to justify chasing strength.
Latest reported quarter: 2026/Q2. Revenue rose to $754.177M (+6.11% YoY). Net income increased to $34.169M (+31.72% YoY) and EPS to $1.36 (+32.04% YoY), indicating strong bottom-line leverage. The main blemish is gross margin, which fell to 18.54% (-7.94% YoY), suggesting cost pressure or mix headwinds even as earnings grew.
No analyst rating/price target change data was provided, so a recent trend assessment isn’t available. Wall Street pros/cons view cannot be inferred from the dataset; based only on fundamentals here, the pro case is accelerating EPS growth, while the con case is declining gross margin and a technically overbought entry point.
